Annis Gardner Whiting Capital Advisors, LLC Exact Sciences Corp Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $279 Billion
- Q1 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 9,135 shares of EXAS stock, worth $407,146. This represents 0.23% of its overall portfolio holdings.
Number of Shares
9,135
Previous 6,940
31.63%
Holding current value
$407,146
Previous $513 Million
22.87%
% of portfolio
0.23%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
699Shares Held
160MCall Options Held
5.84MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$791 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$581 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$552 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$507 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$476 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.89B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...